Want to see HK:0897 full AI Analyst Report?
Wai Yuen Tong Medicine Holdings Limited (0897) AI Stock Analysis
Wai Yuen Tong Medicine Holdings Limited
(HKEX:0897)
The overall score reflects mixed but stable finances, with declining revenue and inconsistent operating profitability offset by solid margins, positive cash flow, and reduced leverage, while an expensive valuation and overbought technicals limit upside and add near-term risk.
Wai Yuen Tong Medicine Holdings Limited (0897) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 401.18M
- Dividend Yield
- ―
- Average Volume (3M)
- 588.03K
- Price to Earnings (P/E)
- 100.0
- Beta (1Y)
- 0.70
- Revenue Growth
- -8.30%
- EPS Growth
- -44.44%
- Country
- Hong Kong
- Employees
- 691
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Wai Yuen Tong Medicine Holdings Limited Business Overview & Revenue Model
Company Description
Wai Yuen Tong Medicine Holdings Limited operates as an investment holding company with a multifaceted business portfolio. Its core activities encompass the production, processing, and retail distribution of traditional Chinese medicines, Western phar...
How the Company Makes Money
The company primarily makes money by selling products—especially traditional Chinese medicines and health-related consumer products—through its retail and distribution operations. Key revenue streams generally include (i) retail sales through branded...
Wai Yuen Tong Medicine Holdings Limited Financial Statement Overview
Summary
Revenue has declined for two consecutive years and operating profit remains negative, but healthy gross margins, positive cash generation, and a strengthening balance sheet support basic financial stability.
Income Statement
58NeutralBalance Sheet
71PositiveCash Flow
62Positive| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 683.44M | 683.44M | 745.30M | 783.88M | 1.29B | 1.39B |
| Gross Profit | 361.93M | 361.93M | 376.45M | 394.81M | 609.54M | 574.15M |
| EBITDA | 68.00M | 67.05M | 122.72M | 140.21M | 128.45M | 156.19M |
| Net Income | 3.99M | 3.99M | 7.10M | -15.36M | -20.52M | -108.91M |
Balance Sheet | ||||||
| Total Assets | 1.63B | 1.63B | 1.74B | 2.10B | 7.01B | 7.60B |
| Cash, Cash Equivalents and Short-Term Investments | 147.44M | 147.44M | 146.55M | 196.78M | 625.01M | 683.74M |
| Total Debt | 279.29M | 279.29M | 435.41M | 560.07M | 1.76B | 1.80B |
| Total Liabilities | 446.01M | 446.01M | 555.68M | 709.65M | 3.33B | 3.64B |
| Stockholders Equity | 1.18B | 1.18B | 1.18B | 1.39B | 2.35B | 2.52B |
Cash Flow | ||||||
| Free Cash Flow | 86.21M | 56.94M | 75.16M | 157.04M | 58.13M | 90.14M |
| Operating Cash Flow | 99.70M | 70.43M | 102.32M | 191.69M | 91.58M | 116.18M |
| Investing Cash Flow | 25.68M | 71.13M | 280.89M | -84.62M | 15.06M | -15.91M |
| Financing Cash Flow | -124.49M | -140.67M | -405.69M | -469.97M | -67.25M | -115.27M |
Wai Yuen Tong Medicine Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0897, the sentiment is Positive. The current price of 0.36 is below the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.35, and above the 200-day MA of 0.33, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 50.28 is Neutral, neither overbought nor oversold. The STOCH value of 51.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0897.
Wai Yuen Tong Medicine Holdings Limited Peers Comparison
Overall Rating
HK:023977Outperform
HK:095068Neutral
HK:689664Neutral- HK:089756Neutral
HK:057053Neutral
HK:149842Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:0239 | 77Outperform | HKD 774.43M | 7.76 | 13.59% | 7.44% | 10.63% | 39.44% |
| HK:0950 | 68Neutral | HKD 606.50M | 3.64 | 8.02% | 5.61% | 7.05% | 22.46% |
| HK:6896 | 64Neutral | HKD 1.44B | 5.80 | 16.70% | 17.44% | -5.37% | -18.03% |
| HK:0897 | 56Neutral | HKD 401.18M | 100.00 | 0.34% | ― | -8.30% | -44.44% |
| HK:0570 | 53Neutral | HKD 5.89B | -4.80 | -4.98% | 0.30% | -15.80% | -298.94% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:1498 | 42Neutral | HKD 123.04M | -4.04 | -21.66% | ― | -6.71% | 43.14% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0897 | Wai Yuen Tong Medicine Holdings Limited | 0.36 | -0.09 | -20.00% | |
| HK:0570 | China Traditional Chinese Medicine Holdings Co | 1.17 | -1.14 | -49.35% | |
| HK:0950 | Lee's Pharmaceutical Holdings Limited | 1.03 | -0.73 | -41.41% | |
| HK:1498 | PuraPharm Corp. Ltd. | 0.23 | -0.17 | -42.50% | |
| HK:0239 | Pak Fah Yeow International Limited | 2.48 | 0.25 | 11.09% | |
| HK:6896 | Golden Throat Holdings Group Co Ltd | 1.95 | -1.16 | -37.32% |
Wai Yuen Tong Medicine Holdings Limited Corporate Events
Wai Yuen Tong Wins Strong Shareholder Backing for Capital Flexibility at AGM
Shareholders of Wai Yuen Tong Medicine Holdings Limited have overwhelmingly approved all resolutions at the annual general meeting held on 19 August 2026 in Hong Kong. The meeting endorsed the audited financial statements for the year ended 31 March...
Wai Yuen Tong Gains Listing Rule Waiver for Delayed Disposal Circular
Wai Yuen Tong Medicine Holdings Limited has announced a delay in sending a shareholder circular related to the disposal of its entire interest in Guanzun (Shenzhen) Trade Development Co., Ltd. The company required additional time to prepare and final...
Wai Yuen Tong Sets 2026 AGM to Approve Financials and Share Issue Mandate
Wai Yuen Tong Medicine Holdings Limited has convened its annual general meeting for 19 August 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and directors’ and auditor’s reports for the yea...
Wai Yuen Tong Updates Registered Office Address in Bermuda
Wai Yuen Tong Medicine Holdings Limited announced that it will change the address of its registered office in Bermuda to Richmond House, 12 Par-la-Ville Road, Hamilton HM 08, with effect from 3 August 2026. The move updates the company’s legal...
Wang On, Wai Yuen Tong to Divest Property-Holding Unit in Major HK Transaction
Wang On Group and its subsidiary Wai Yuen Tong Medicine have agreed to sell the entire issued share capital of a property-holding target company for RMB99.8 million, or about HK$115.44 million. Upon completion, both groups will cease to hold any inte...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 18, 2026